IRTC receives FDA 510(k) clearance for prior design modifications to its Zio AT device, reinforcing its commitment to quality and compliance.
Vous n'êtes pas connecté
IRTC launches Zio monitor in Austria, Netherlands, Spain and Switzerland, which offers 14-day continuous ECG monitoring, enhancing arrhythmia diagnosis and patient care.
IRTC receives FDA 510(k) clearance for prior design modifications to its Zio AT device, reinforcing its commitment to quality and compliance.
Created with DBE pioneer Prof. Yamamoto, Fujifilm's new DBE endoscope offers precision imaging and patient safety for small bowel diagnosis and...
Accurately diagnosing the state of electric vehicle (EV) batteries is essential for their efficient management and safe use. KAIST researchers have...
New products aimed at enhancing soil health and turf quality for golf courses and sports fields.
The Queen Elizabeth Hospital (QEH) has announced plans to introduce a clinical pharmacy service as part of its 2025-2028 Strategic Plan, aimed at...
As artificial intelligence (AI) continues to transform industries across the globe, organisations are grappling with the ways in which to effectively...
COVID-19 is here to stay. As restrictions and human testing have waned, new research is tackling the challenge of how we can monitor, predict, and...